In a bid to combat the resurgence of potentially debilitating Clostridioides difficile infection (CDI), healthcare professionals have pivoted towards new therapeutics. Clostridioides difficile, a bacterium that colonizes the gut, incites a disruption in the gut microbiome leading to dysbiosis, thereby paving the way for infections. Posing a higher risk to the elderly (over 65), the…